About PSM
Consumer Protection Group Supports West African Anti-Counterfeit Drug Efforts
Partnership for Safe Medicines shares expertise with leaders to combat contraband and counterfeit drugs.
ACCRA, Ghana (Sept. 9, 2008) – To combat the increasing amounts of contraband and counterfeit drugs threatening public health, West African government officials, business leaders, and non-profit organizations gathered today for the Stakeholder Forum on Safe Medicines in Accra, Ghana. The Partnership for Safe Medicines, a coalition of organizations and individuals dedicated to protecting consumers from counterfeit medicines, helped lead a discussion about how the region can work together to address this important health problem.
[...]Thomas T. Kubic
Thomas T. Kubic is the President and CEO of the Pharmaceutical Security Institute (PSI), a non-profit association dedicated to protecting the public health by insuring the distribution of pharmaceuticals that are safe and effective. Mr. Kubic previously served on the World Health Organization’s IMPACT Enforcement Working Group. With the 2013 launch of the Pharmaceutical Industry Initiative to Combat Crime (PIICC), he participated in the Technical Committee to assist Interpol’s global efforts to address pharmaceutical crime. He is an industry advisor to the Permanent Forum Against International Pharmaceutical Counterfeiting. Additionally, he has provided testimony before senior government officials around the world concerning the international nature of counterfeiting and its devastating impact. He is a Director and the Treasurer for the Partnership for Safe Medicines.
Partnership for Safe Medicines Issues Statements on Series of Drug Safety Hearings
Recently, the heparin contamination and drug safety in general have taken center stage on Capitol Hill. In the past two weeks, there has been three hearings in the House and one in the Senate examining issues affecting the safety of our prescription medicines.
[...]Heparin Update: 62 Suspected U.S. Fatalities, 2 Upcoming Hearings
The heparin fallout continues. As an update to our March 13 post, the Food and Drug Administration (FDA) now reports 62, not 19, suspicious deaths in the United States linked to the blood thinner heparin, most of which occurred in December, January and February. According to an article in the New York Times, investigations continue into whether the deaths were caused by the Chinese contaminant.
[...]Bryan A. Liang, MD, PhD, JD
Vice President Bryan A. Liang, Ph.D, M.D., J.D. Professor of Anesthesiology Director, San Diego Center for Patient Safety, University of California San Diego School of Medicine Professor Bryan A. Liang is Professor of Anesthesiology and Director, San Diego Center for Patient Safety, University of California, San Diego School of Medicine as well as Vice President, Partnership for Safe Medicines.…
[...]A Second Article
Take a look at the Safe Medicines Blog.
[...]A Test News Story From About Us
A short blurb about the news story.
[...]Partnership for Safe Medicines Commends New Anti-Counterfeiting Agreement
WASHINGTON, D.C. (Oct. 24, 2007) — The Partnership for Safe Medicines commends yesterday's announcement by the U.S. Trade Representative of a new six-country Anti-Counterfeiting Trade Agreement (ACTA). The purpose of ACTA is to step up enforcement efforts against international counterfeiters.
[...]Shepherd, M.* Drug Importation and Safety of Drugs Obtained from Canada. Ann Pharmacother. 2007;41:1288-1291.
Drug importation from Canada has been hotly debated for nearly a decade. Many believe that drug importation will bring needed competition and lower US drug prices. Opposition argues that the costs of ensuring product quality and safety, as well as added healthcare costs, will offset savings attained from imported pharmaceuticals. The US needs to become…
[...]Shepherd, M.* Impact of drug importation on community pharmacy and patient care. J Am Pharm Assn. 2007; 47(3):319-327
With the politcal powers shifting in both congressional houses, many pharmaceutical issues have resurfaced in the 110th Congress. One of these is legalization of drug importation. Many Democrats and Republicans have already stated that this is a high-priority item. In the first 60 days of the First Session, two bills were introduced that would legalize…
[...]